Haima Therapeutics LLC
Cleveland, OH
- UEI
- JKZPL4NA9V21
- CAGE
- 7P1L6
- Primary NAICS
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 11000 Cedar Ave # 280, Cleveland, OH 44106, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| IND-enabling preclinical evaluation of a field-deployable synthetic | Defense Advanced Research Projects Agency | $2,000,000 | |
| A novel platelet-inspired nanotechnology to restore hemostasis in patients on antiplatelet agents - project… | National Heart Lung and Blood Institute | $1,972,894 | |
| Research drug-loaded liposomes | Veterans Integrated Service Network 10 | $17,500 | |
| Research and development - proposal log no. RC190267, a nanotechnology-enabled biosynthetic whole-blood surrogate for… | Medical Command | $1,623,731 | |
| Synthoplate-enriched plasma for enhanced hemostatic resuscitation in trauma | Defense Health Agency | $1,386,698 |
About Haima Therapeutics LLC
Haima Therapeutics LLC is a Cleveland, Ohio-based woman-owned small business and limited liability company registered in SAM.gov since 2016. The organization specializes in developing advanced nanotechnology solutions focused on hemostatic treatments and platelet-inspired therapeutic interventions. Its core expertise appears to center on innovative medical research and development of synthetic platelet technologies that can address critical medical challenges, particularly in trauma and bleeding management scenarios.
Through its federal contract history, Haima Therapeutics LLC has executed a small purchase order valued at $17,500 with the Veterans Integrated Service Network 10, specifically for research involving drug-loaded liposomes. The contract was not set aside for any specific business category and was completed on September 15, 2022. While the contract award history is limited, it suggests the company's capability to perform specialized research-oriented procurement work for federal medical service networks.
Haima Therapeutics LLC has been more prominently engaged through federal grant awards, particularly with the National Heart, Lung, and Blood Institute. Its primary grant work involves developing a novel platelet-inspired nanotechnology called Synthoplate (SP), designed to restore hemostasis in patients using antiplatelet agents. The $944,676 project grant focuses on creating a donor-independent therapeutic to reduce bleeding complications in traumatic brain injury patients. Additionally, the company has participated in a sub-grant with Case Western Reserve University, developing field-deployable dried platelet surrogate nanotechnology for hemorrhage control, specifically targeting military combat-associated traumatic hemorrhage scenarios. These grants demonstrate the company's advanced research capabilities in developing innovative medical technologies with significant potential impact on trauma and emergency medical treatment.
SBA capabilities narrative
Research, development, and commercialization of therapeutic to mitigate bleeding inn non-compressible hemorrhage and other bleeding complications.
Quick answers
What is Haima Therapeutics LLC's UEI?
Haima Therapeutics LLC's Unique Entity ID (UEI) in SAM.gov is JKZPL4NA9V21.
What is Haima Therapeutics LLC's CAGE code?
Haima Therapeutics LLC's CAGE code is 7P1L6.
What is Haima Therapeutics LLC's primary NAICS code?
Haima Therapeutics LLC's primary NAICS code is 541715 (Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)).
Where is Haima Therapeutics LLC located?
Haima Therapeutics LLC's physical address in SAM.gov is 11000 Cedar Ave # 280, Cleveland, OH 44106, USA.
Is Haima Therapeutics LLC registered in SAM.gov?
Yes. Haima Therapeutics LLC's SAM.gov registration is active through October 13, 2026.
What is Haima Therapeutics LLC's most recent federal award?
Haima Therapeutics LLC's most recent federal contract award is IND-enabling preclinical evaluation of a field-deployable synthetic (HR0011259E017), from Defense Advanced Research Projects Agency, on September 19, 2025.
On GovTribe
See Haima Therapeutics LLC's full federal record
- Federal contract awards
- IDV awards
- Federal grant awards
- Subcontracting relationships
- Funding analysis by agency, NAICS and set-aside
- Similar vendors